Rezatapopt Revolutionizes Research Directions in TP53-Mutate

Shivaani Kummar, MBBS, FACP, discusses the mechanism of action of the TP53-directed agent rezatapopt and efficacy data with this agent in solid tumors.

Related Keywords

California , United States , Portland , Oregon , San Diego , Shivaani Kummar , Division Of Hematology Medical Oncology , Pharmaceuticals Inc , Cancer Research , Oregon Health Science University School Of Medicine , International Conference On Molecular , Knight Cancer Institute , Lester Dearmond Endowed Chair , Medical Oncology , Oregon Health , Science University School , Experimental Therapeutics , Knight Cancer , Molecular Targets ,